Wang Yongjun
Wang Yongjun is a renowned Chinese clinical scientist and a leading figure in the field of stroke research. He has made significant contributions over four decades, particularly in the areas of ischemic stroke treatment and secondary prevention strategies. As the founder and president of the Chinese Stroke Association and the director of the Neurology Division of the Chinese Medical Association, Wang has spearheaded major clinical trials, including the influential CHANCE and TRACE studies. His groundbreaking work has reshaped global stroke treatment guidelines and earned him numerous accolades, including the prestigious William M. Feinberg Stroke Excellence Award in 2025, marking the first time an Asian scientist has received this honor.
Not in the pool (under ¢1).
Recent news mentions
Wang Yongjun contributed to the meeting discussions.
听取对政府工作报告、“十五五”规划纲要的意见建议 --时政--人民网
China· 2026-01-20
Wang Yongjun spoke at the meeting.
李强主持召开专家、企业家和教科文卫体等领域代表座谈会 听取对政府工作报告、“十五五”规划纲要的意见建议--时政--人民网China· 2026-01-19Wang Yongjun views the establishment of 1000 rural museums as a way to connect and preserve rural culture in Zhejiang.
在乡村建1000个博物馆：守住乡愁 文化新生 _光明网China· 2025-09-12
Wang Yongjun was awarded the 'William M. Feinberg Stroke Excellence Award' for his global contributions in the field of stroke research and clinical practice.
王拥军：“硬控”卒中四十年（中华名医） --健康·生活--人民网China· 2025-02-10
